US 12,391,645 B2
N-isopropyl tryptamines and method of making monoalkylated and dialkylated tryptamine analogs
Andrew R. Chadeayne, Issaquah, WA (US)
Assigned to CAAMTECH, INC., Issaquah, WA (US)
Appl. No. 18/865,727
Filed by CAAMTECH, INC., Issaquah, WA (US)
PCT Filed May 22, 2023, PCT No. PCT/US2023/067304
§ 371(c)(1), (2) Date Nov. 14, 2024,
PCT Pub. No. WO2023/225679, PCT Pub. Date Nov. 23, 2023.
Claims priority of provisional application 63/385,263, filed on Nov. 29, 2022.
Claims priority of provisional application 63/385,312, filed on Nov. 29, 2022.
Claims priority of provisional application 63/385,289, filed on Nov. 29, 2022.
Claims priority of provisional application 63/385,320, filed on Nov. 29, 2022.
Claims priority of provisional application 63/385,267, filed on Nov. 29, 2022.
Claims priority of provisional application 63/344,145, filed on May 20, 2022.
Prior Publication US 2025/0197352 A1, Jun. 19, 2025
Int. Cl. C07D 209/16 (2006.01)
CPC C07D 209/16 (2013.01) 2 Claims
 
1. Crystalline form 1 of [2-(5-chloro-1H-indol-3-yl)ethyl](propan-2-yl)azanium iodide (5-chloro-N-isopropyltryptammonium iodide).